In this study, we demonstrated, both in vitro and in vivo, that the EWSR1-PSMC5 fusion gene can contribute to osteosarcoma's resistance to chemotherapy by influencing autophagy and other related signaling pathways. The gene discussed is EWSR1; the disease is osteosarcoma.